Dr. Hector H. Bolivar, MD

Dr. Bolivar practices at Midway Specialty Care Center Inc in Fort Pierce, Florida.

Dr. Bolivar's NPI, 1558398206, was assigned on June 27, 2006. Dr. Bolivar graduated from Other in 1989. Dr. Bolivar holds Florida license ME87472.

Dr. Bolivar's primary practice is Midway Specialty Care Center Inc, at 356 E Midway Rd, Fort Pierce, FL 34982 in Saint Lucie County. The practice phone is (772) 464-9746.

Dr. Bolivar's primary practice is Midway Specialty Care Center Inc in Fort Pierce, Florida. Dr. Bolivar is also affiliated with Jackson Memorial Hospital. The medical group on file is Midway Specialty Care Center. Dmand AI also links Dr. Bolivar to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolivar practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bolivar's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Bolivar is board certified in infectious disease by the American Board of Internal Medicine. Dr. Bolivar is licensed in Florida.

Dmand AI lists bronchitis and hiv/aids among the conditions Dr. Bolivar treats.

CMS data shows 42 Medicare services from Dr. Bolivar across 2 procedure codes in 2024, for 21 Medicare patients. Medicare paid $2,077 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Bolivar in 2024. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bolivar's median patient age at 64, with 31% women.

In 2024, Dr. Bolivar wrote 292 Medicare Part D claims for 22 patients. 48% of them were for generic drugs. CMS names the drug for 168 of them, across 9 drugs with 11 or more claims each, at $335,170 in total drug cost. In 2023, CMS named 123 claims across 7 drugs.

Dr. Bolivar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 38 papers to Dr. Bolivar, published from 2005 to 2023. 2020 was the busiest year, with 5. The most frequent topics are HIV Infections, HIV-1 and Accidental Falls. Dr. Bolivar has published most often in J Acquir Immune Defic Syndr. Dr. Bolivar's most frequent co-authors are Kathleen M. Weber, MD, Seble Kassaye, MD and Phyllis Tien.

Dmand AI links Dr. Bolivar to 4 clinical trials, 2 of them phase 3 studies. Conditions studied include Acquired Immunodeficiency Syndrome, COVID-19 and Pneumonia, Viral. Open Payments lists research payments to Dr. Bolivar that name 1 trial.

CMS Open Payments shows 339 general payments to Dr. Bolivar from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. ViiV Healthcare Company paid the most, $16,054. It also lists 23 research payments totaling $91,947 from 2018 to 2024, naming 1 clinical trial.

Dr. Bolivar graduated from Other in 1989. Dr. Bolivar is a member of ACP.

Dr. Bolivar is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.